Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

NCT02891811

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Med. Universität Innsbruck, Univ.-Klinik f. Innere Medizin V, Hämatologie u. Onkologie Innsbruck, Austria
  • Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik Kufstein, Austria
  • LKH Hochsteiermark - Standort Leoben Abteilung für Innere Medizin und Hämatologie und internistische Onkologie Leoben, Austria
View all 21 locations
View Trial Details
Completed

Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

NCT02119468

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

COVID-19 Infection and Multiple Myeloma

NCT04492371

Conditions
Blood Protein Disorders, COVID-19, Cardiovascular Diseases, +26 more
Locations
  • General Hopspital Vienna/Medical University Vienna, Austria
  • UCL Saint-Luc Brussels, Belgium
  • University Hospital Ostrava Ostrava, Czechia
  • University Hospital Würzburg Würzburg, Germany
View Trial Details
Completed

Vaccine Therapy in Treating Patients With Multiple Myeloma

NCT00019097

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
Locations
  • Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Medicine Branch Bethesda, Maryland, United States
View Trial Details

Related conditions